Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

The compound 4c effectively inhibits the enzyme linked to hair loss.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Ticagrelor works better than clopidogrel in reducing platelet activity in elderly patients with acute coronary syndrome.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

New devices may treat heart failure more effectively than drugs.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.